Effects of bradykinin on signal transduction, cell proliferation, and cytokine, prostaglandin E2 and collagenase-1 release from human corneal epithelial cells

British Journal of Pharmacology

Volumn 123, Issue 6, 1998, Pages 1127-1137

  Wiernas, T K ^a,b   Davis, T L ^a   Griffin, B W ^a,b   Sharif, N A ^a,b  

^a ALCON RESEARCH LTD   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Bradykinin; Bradykinin receptors; Collagenase 1; Conjunctivitis; Corneal epithelium; Cytokine; Hoe 140; Inflammation; PGE2; Wound healing

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; BRADYKININ; BRADYKININ B2 RECEPTOR; CALCIUM ION; CELL DNA; COLLAGENASE; CYTOKINE; EGTAZIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ICATIBANT; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; NIFEDIPINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; PROSTAGLANDIN E2;

ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CELL MEMBRANE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOKINE RELEASE; DNA SYNTHESIS; ENZYME RELEASE; EPITHELIUM CELL; FETAL CALF SERUM; HUMAN; HUMAN CELL; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WOUND HEALING;

BRADYKININ; CALCIUM; CELL DIVISION; CELL LINE, TRANSFORMED; COLLAGENASES; CORNEA; CYTOKINES; DINOPROSTONE; EPITHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 1; PHOSPHATIDYLINOSITOLS; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRITIUM;

EID: 0031912580     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701700     Document Type: Article

References (52)

1. ABELSON, M.B. & SCHAEFER, K. (1993). Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Survey Ophthalmol. 38, 115-132.
2. ALLANSMITH, M.R. & ROSS, R.N. (1988). Ocular Allergy. Clin. Allergy, 18, 1-13.
3. ARAKI-SASAKI, K., OHSAKI, Y., SASABE, T., HAYASHI, K., WATANABE, H., TANO, Y. & HANDA, H. (1995). An SV40-immortalized human corneal epithelial cell line and its characterization. Invest. Ophthalmol. Vis. Sci., 36, 614-621.
4. 2 bradykinin receptors in a fibrosarcoma cell line. Cell. 30, 243-251.
5. BENEZRA, D., GRIFFIN, B.W., MAFTZIR, G., SHARIF, N.A. & CLARK, A.F. (1997). Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest. Ophthalmol. Vis. Sci., 38, 1954-1962.
6. BERRIDGE, M.J. (1993). Inositol trisphosphate and calcium signalling. Nature, 361, 315-325.
7. BERRIDGE, M.J., DOWNES, C.P. & HANLEY, M.R. (1982). Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary gland. Biochem. J., 206, 587-595.
8. BERRIDGE, M.J. & IRVINE, R.F. (1984). Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature, 312, 315-321.
9. BEUERMEN, R.W., CROSSON, C.E. & KAUFMAN, H.E. (ed.) (1989). Healing Processes in The Cornea; Advances in Applied Biotechnology Series, Volume 1. London: Gulf publishing company.
10. BLEASDALE, J.E., THAKUR, N.R., GREMBAN, R.S., BUNDY, G.L., FITZPATRICK, F.A., SMITH, R.J. & BUNTING, S. (1990). Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J. Pharmacol. Exp. Ther., 255, 756-768.
11. I receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction and phosphatidylinositol hydrolysis. Br. J. Pharmacol., 114, 612-617.
12. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
13. CUBITT, C.L., TANG, Q., MONTERIO, C.A., LAUSCH, R.N. & OAKES, J.E. (1993). IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci., 34, 3199-3206.
14. 2 bradykinin receptor affinity forms. Eur. J. Cell. Biol., 69, 236-244.
15. ELLIOTT, P.J., MACKIC, J.B, GRANEY, W.F., BARTUS, R.T. & ZLOKOVIC, B.V. (1995). RMP-7, bradykinin agonist, increases permeability of blood-ocular barriers in the guinea pig. Invest. Ophthalmol. Vis. Sci., 36, 2542-2547.
16. FAQUET, B., BUIATTI-TCHENG, M., TROMVOUKIS, Y., OFFORD, E.A. & LECLAIRE, J. (1997). Cytokine production after treatment with surfactants in a human corneal epithelial cell line. Invest. Ophthalmol. Vis. Sci., 38, (suppl.) Abst. No. 4046.
17. FIGINI, M., JAVDAN, P., CIONCOLINI, F. & GEPPETTI, P. (1995). Involvement of tachykinins in plasma extravasation induced by bradykinin and low pH medium in the guinea pig conjunctiva. Br. J. Pharmacol., 115, 128-132.
18. 2+ pool depletion. J. Biol. Chem., 271, 883-888.
19. GRIFFIN, B.W., WILLIAMS, G.W., CRIDER, J.Y. & SHARIF, N.A. (1997). FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study. J. Pharmacol. Expl. Ther., 281, 845-854.
20. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
21. HALL, J.M. (1992). Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther., 56, 131-190.
22. 2 receptor antagonist WIN-64338 in vivo and in vitro. Br. J. Pharmacol., 116, 3164-3168.
23. KAHN, C.R., YOUNG, E., LEE, I.H, & REHM, J.S. (1993). Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies. Invest. Ophthalmol. Vis. Sci., 34, 3429-3441.
24. LERNER, U.H., SAHLBERG, K. & LJUNGGREN, O. (1989). Thrombin and bradykinin enhance prostaglandin production in human peripheral blood monocytes. J. Oral Pathol. Med., 18, 246-250.
25. LOWE, W.L., YOREK, M.A. & TEASDALE, R.M. (1993). Ligands that activate protein kinase-C differ in their ability to regulate basic fibroblast growth factor and insulin-like growth factor-1 messenger ribonucleic acid levels. Endocrinology., 132, 1593-1602.
26. MARCEAU, F., LUSSIER, A., REGOLI, D. & GIROUD, J.P. (1983). Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen. Pharmacol., 14, 209-229.
27. MCALLISTER, B.S., LEEB-LUNDBERG, L.M., JAVORS, M.A. & OLSON, M.S. (1993). Bradykinin receptors and signal transduction pathways in human fibroblasts: integral role for extracellular calcium. Arch. Biochem. Biophys., 304, 294-301.
28. MCPHERSON, G.A. (1983a). A practical computer based approach to the analysis of radioligand binding experiments. Computer Prog. Biomed., 17: 107-114.
29. MCPHERSON, G.A. (1983b). Analysis of radioligand binding experiments on a microcomputing system. Trends Pharmacol. Sci., 4: 369-370.
30. MICHEL, A.D. & WHITING, R.L. (1984). Analysis of ligand binding data using a microcomputer. Br. J. Pharmacol., 83, 460P.
31. 2 receptors in the respective control of cell growth and phospholipid hydrolysis. Cancer Res., 52, 334-340.
32. PROIA, A.D. (1994). Inflammation. In Pathobiology of Ocular Disease, ed. Garner A. & Klintworth, G.K., Chapter 2, pp. 63-99. New York: Marcel Dekker.
33. PROUD, D., SWEET, J., STEIN, P., SETTIPANE, R.A., KAGEYSOBOTKA, A., FREIDLAENDER, M.H. & LICHTENSTEIN, L.M. (1990). Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J. Allergy Clin. Immunol. 85, 896-905.
34. 2-bradykinin receptor on a subclone of PC-12 cells. J. Neurochem., 56, 983-989.
35. REIM, M., KOTTEK, A. & SCHERAGE, N. (1997). The cornea surface and wound healing. Prog. Retinal Eye Res., 16, 183-225.
36. ROSCHER, A., KLIER, C., DENGLER, R., FAUBNER, A. & MULLERESTERL, W. (1990). Regulation of bradykinin action at the receptor level. J. Cardiovase. Pharmacol., 15, S39-S43.
37. ROSENBAUM, J.T., PLANCK, S.R., HUANG, X-N, RIC, L. & ANSEL, J.C. (1995). Detection of mRNA for the cytokines, interleukin-1α, and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest. Ophthalmol. Vis. Sci., 36, 2151 -2155.
38. SHARIF, N.A., CRIDER, J.Y., GRIFFIN, B.W., DAVIS, T.L. & HOWE, W. E. (1997a). Pharmacological analysis of mast cell mediator and neurotransmitter receptors coupled to adenylate cyclase and phospholipase C on immunocytochemically-defined human conjunctival epithelial cells. J. Ocular Pharmacol. Ther., 13, 321-336.
39. 2-receptor. Neurosci. Lett., 86, 279-283.
40. SHARIF, N.A., OFFORD, E.A., TROMVOUKIS, Y., HOWE, W.E., GRIFFIN, B.W., WIERNAS, T.K. & PFEIFER, A.M.A. (1997b). Immortalized human corneal epithelial (CEPI) cells for use in ocular inflammation and toxicity studies. Invest. Ophthalmol. Vis. Sci., 38, (suppl.), Abst. No. 3349.
41. SHARIF, N.A. & STEVENSON, D.J. (1993). Chinese hamster ovary (CHO-K1) cells: optimum culture conditions, cell-cycle events and phospholipid metabolism in response to serum and calcium ionophore A23187. Med. Sci. Res., 21, 553-556.
42. 2-bradykinin receptors in guinea pig brain regions, spinal cord and peripheral tissues. Neurochem. Int., 18, 89-96.
43. 2-antagonist-sensitive responses and receptor binding studies. Neurochem. Res., 12, 1313-1320.
44. SHARIF, N.A. & XU, S.X. (1996). Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-immortalized human trabecular meshwork cells. Exp. Eye Rex., 63, 631-637
45. SHARIF, N.A., XU, S.X., MILLER, S.T., GAMACHE, D.A. & YANNI, J.M. (1996). Characterization of the ocular anti-allergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J. Pharmacol. Exp. Ther., 278, 1251-1260.
46. 2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol. Pharmacol., 47, 525-534.
47. TONES, M.A., SHARIF, N.A. & HAWTHORNE, J.N. (1988). Phospholipid turnover during cell-cycle traverse in synchronous Chinesehamster ovary cells. Biochem. J., 249, 51-56.
48. VERNHET, L., HICHAMI, A., HAMON, L. COCHET, M.F. & LEGRAND, A.B. (1996). Incorporation of 12(S)-hydroxyeicosatetrenoic acid into phospholipids and active diacylglycerols in rat liver epithelial cells: effects on DNA synthesis. J. Lipid Mediator Cell. Signal., 13, 233-248.
49. WAKEFIELD, D. & LLOYD, A. (1992). The role of cytokines in pathogenesis of inflammatory eye disease. Cytokine, 4, 1-5.
50. WEBER, K.T., SUN, Y. & KATWA, L.C. (1996). Wound healing following myocardial infarction. Clin. Cardiol., 19, 447-455.
51. 2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists. Br. J. Pharmacol., 121, 649-656.
52. ZICHE, M., PARENTI, A., MORBIDELLI, L, MEININGER, C.J., GRANGER, H.J. & LEDDA, F. (1992). The effects of vasoactive factors on the growth of coronary endothelial cells. Cardiologia 37, 573-575.